市場調査レポート

商品コード

月経困難症治療薬市場：タイプ別、治療法別、診断別、処方形態別、投与経路別、エンドユーザー別-2023-2030年の世界予測

Dysmenorrhea Treatment Market by Type, Treatment, Diagnosis, Mode of Prescription, Route of Administration, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 743,598円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 900,178円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,056,758円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,369,918円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.58円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

月経困難症治療薬の世界市場は、2023年にはCAGR 10.32%で66億1,552万米ドルと予測され、2030年には132億1,652万米ドルという驚異的な規模に達すると予測され、大きな成長が見込まれています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の月経困難症治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.月経困難症治療薬の世界市場規模および予測は？

2.予測期間中、世界の月経困難症治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.月経困難症治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.月経困難症治療薬の世界市場における競争戦略は？

5.月経困難症治療薬の世界市場における技術動向と規制の枠組みは？

6.月経困難症治療薬の世界市場における主要ベンダーの市場シェアは？

7.月経困難症治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 思春期の少女の間で月経困難症の有病率が上昇
  - 意識を高めるための政府の措置の増加
  - 高齢者人口の増加により月経困難症治療薬が使用される
- 抑制要因
  - 月経困難症治療薬に関連する副作用と合併症
- 機会
  - 月経困難症の管理におけるイノベーション
  - 継続的な研究開発活動
- 課題
  - 女性のリプロダクティブ・ヘルスに関する認識が限られている
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章月経困難症治療薬市場：タイプ別

原発性月経困難症
続発性月経困難症

第7章月経困難症治療薬市場治療別

投薬
手術
治療

第8章月経困難症治療薬市場診断別

CTスキャン
腹腔鏡検査
磁気共鳴画像
超音波

第9章月経困難症治療薬市場処方方法別

店頭
処方

第10章月経困難症治療薬市場：投与経路別

インプラント
オーラル
非経口

第11章月経困難症治療薬市場：エンドユーザー別

ホームケア
病院
専門クリニック

第12章南北アメリカの月経困難症治療薬市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第13章アジア太平洋地域の月経困難症治療薬市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第14章欧州・中東・アフリカの月経困難症治療薬市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第15章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第16章掲載企業一覧

第17章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. DYSMENORRHEA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. DYSMENORRHEA TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 5. DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 6. DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2022 VS 2030 (%)
FIGURE 7. DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2022 VS 2030 (%)
FIGURE 8. DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 9. DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2022 VS 2030 (%)
FIGURE 10. DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 11. DYSMENORRHEA TREATMENT MARKET DYNAMICS
FIGURE 12. DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 23. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 5. DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 12. DYSMENORRHEA TREATMENT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DYSMENORRHEA TREATMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING , BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DYSMENORRHEA TREATMENT MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 17. DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 20. DYSMENORRHEA TREATMENT MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. DYSMENORRHEA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 24. DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 46. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 49. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 50. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 55. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 81. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 82. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 84. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 87. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 88. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 99. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 132. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 135. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 151. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 157. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 160. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 163. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 166. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 169. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 175. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 178. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 187. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 190. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 191. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 205. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 208. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 211. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 214. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 215. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 217. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 220. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 221. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 241. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 244. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 259. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 262. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 277. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 278. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 279. DYSMENORRHEA TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-742BD517DAB3

The Global Dysmenorrhea Treatment Market is forecasted to grow significantly, with a projected USD 6,615.52 million in 2023 at a CAGR of 10.32% and expected to reach a staggering USD 13,216.52 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Dysmenorrhea Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Dysmenorrhea Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Primary Dysmenorrhea and Secondary Dysmenorrhea. The Primary Dysmenorrhea is projected to witness significant market share during forecast period.

Based on Treatment, market is studied across Medication, Surgery, and Therapy. The Surgery is projected to witness significant market share during forecast period.

Based on Diagnosis, market is studied across CT Scan, Laparoscopy, Magnetic Resonance Imaging, and Ultrasound. The Ultrasound is projected to witness significant market share during forecast period.

Based on Mode of Prescription, market is studied across Over the Counter and Prescription. The Over the Counter is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Implants, Oral, and Parenteral. The Implants is projected to witness significant market share during forecast period.

Based on End-Users, market is studied across Homecare, Hospitals, and Specialty Clinics. The Homecare is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Dysmenorrhea Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Dysmenorrhea Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dysmenorrhea Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dysmenorrhea Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Dysmenorrhea Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Dysmenorrhea Treatment Market?

6. What is the market share of the leading vendors in the Global Dysmenorrhea Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Dysmenorrhea Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Dysmenorrhea Treatment Market, by Type, 2022 vs 2030
4.3. Dysmenorrhea Treatment Market, by Treatment, 2022 vs 2030
4.4. Dysmenorrhea Treatment Market, by Diagnosis, 2022 vs 2030
4.5. Dysmenorrhea Treatment Market, by Mode of Prescription, 2022 vs 2030
4.6. Dysmenorrhea Treatment Market, by Route of Administration, 2022 vs 2030
4.7. Dysmenorrhea Treatment Market, by End-Users, 2022 vs 2030
4.8. Dysmenorrhea Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising prevalence of dysmenorrhea among adolescent girls
  - 5.1.1.2. Increasing number of government measures to raise awareness
  - 5.1.1.3. Growing geriatric population leads to use dysmenorrhea treatment
- 5.1.2. Restraints
  - 5.1.2.1. Associated side effects and complications with dysmenorrhea treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Innovations in management of dysmenorrhea
  - 5.1.3.2. Ongoing research and development activities
- 5.1.4. Challenges
  - 5.1.4.1. Limited awareness about reproductive health in women
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Dysmenorrhea Treatment Market, by Type

6.1. Introduction
6.2. Primary Dysmenorrhea
6.3. Secondary Dysmenorrhea

7. Dysmenorrhea Treatment Market, by Treatment

7.1. Introduction
7.2. Medication
7.3. Surgery
7.4. Therapy

8. Dysmenorrhea Treatment Market, by Diagnosis

8.1. Introduction
8.2. CT Scan
8.3. Laparoscopy
8.4. Magnetic Resonance Imaging
8.5. Ultrasound

9. Dysmenorrhea Treatment Market, by Mode of Prescription

9.1. Introduction
9.2. Over the Counter
9.3. Prescription

10. Dysmenorrhea Treatment Market, by Route of Administration

10.1. Introduction
10.2. Implants
10.3. Oral
10.4. Parenteral

11. Dysmenorrhea Treatment Market, by End-Users

11.1. Introduction
11.2. Homecare
11.3. Hospitals
11.4. Specialty Clinics

12. Americas Dysmenorrhea Treatment Market

12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States

13. Asia-Pacific Dysmenorrhea Treatment Market

13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam

14. Europe, Middle East & Africa Dysmenorrhea Treatment Market

14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom

月経困難症治療薬市場：タイプ別、治療法別、診断別、処方形態別、投与経路別、エンドユーザー別-2023-2030年の世界予測

Dysmenorrhea Treatment Market by Type, Treatment, Diagnosis, Mode of Prescription, Route of Administration, End-Users - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 月経困難症治療薬市場：タイプ別

第7章 月経困難症治療薬市場治療別

第8章 月経困難症治療薬市場診断別

第9章 月経困難症治療薬市場処方方法別

第10章 月経困難症治療薬市場：投与経路別

第11章 月経困難症治療薬市場：エンドユーザー別

第12章 南北アメリカの月経困難症治療薬市場

第13章 アジア太平洋地域の月経困難症治療薬市場

第14章 欧州・中東・アフリカの月経困難症治療薬市場

第15章 競合情勢

第16章 掲載企業一覧

第17章 付録